Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126939251 | 12693925 | 1 | I | 20150415 | 20160822 | 20160829 | 20160829 | EXP | FR-PFIZER INC-2016397158 | PFIZER | 61.00 | YR | M | Y | 0.00000 | 20160829 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126939251 | 12693925 | 1 | PS | Carboplatine Hospira | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 775 MG, SINGLE | 77059 | 775 | MG | SOLUTION FOR INJECTION | |||||||
| 126939251 | 12693925 | 2 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1810 MG, SINGLE | 0 | 1810 | MG | ||||||||
| 126939251 | 12693925 | 3 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1800 MG, SINGLE | 0 | 1800 | MG | ||||||||
| 126939251 | 12693925 | 4 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY EVENING | 0 | 20 | MG | FILM-COATED TABLET | QD | ||||||
| 126939251 | 12693925 | 5 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.25 MG, 3X/DAY (MORNING, MIDDAY, EVENING) | 0 | .25 | MG | TID | |||||||
| 126939251 | 12693925 | 6 | C | CETIRIZINE DIHCL | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0.5 DF, 1X/DAY (EVENING) | 0 | .5 | DF | QD | |||||||
| 126939251 | 12693925 | 7 | C | EUPANTOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | GASTRO-RESISTANT TABLET | QD | ||||||
| 126939251 | 12693925 | 8 | C | EZETROL | EZETIMIBE | 1 | Oral | 10 MG, 1X/DAY (EVENING) | 0 | 10 | MG | TABLET | QD | ||||||
| 126939251 | 12693925 | 9 | C | ISOPTINE | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 240 MG, 1X/DAY (MORNING) | 0 | 240 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 126939251 | 12693925 | 10 | C | JAMYLENE /00061602/ | 2 | Oral | 50 MG, 3X/DAY (MORNING, MIDDAY, EVENING) | 0 | 50 | MG | COATED TABLET | TID | |||||||
| 126939251 | 12693925 | 11 | C | KALEORID LP | POTASSIUM CHLORIDE | 1 | Oral | 1000 MG, 2X/DAY (MORNING, EVENING) | 0 | 1000 | MG | PROLONGED-RELEASE TABLET | BID | ||||||
| 126939251 | 12693925 | 12 | C | SEROPLEX | ESCITALOPRAM OXALATE | 1 | Oral | 5 MG, 1X/DAY (MORNING) | 0 | 5 | MG | FILM-COATED TABLET | QD | ||||||
| 126939251 | 12693925 | 13 | C | SKENAN | MORPHINE SULFATE | 1 | Oral | SKENAN LP 100 MG 1-0-1 | 0 | 1 | DF | QD | |||||||
| 126939251 | 12693925 | 14 | C | SKENAN | MORPHINE SULFATE | 1 | Oral | SKENAN LP 10 MG 1-0-1 | 0 | 1 | DF | QD | |||||||
| 126939251 | 12693925 | 15 | C | SKENAN | MORPHINE SULFATE | 1 | Oral | SKENAN LP 60 MG 1-0-1 | 0 | 1 | DF | QD | |||||||
| 126939251 | 12693925 | 16 | C | SOLUPRED /00016201/ | PREDNISOLONE | 1 | Oral | 20 MG, DAILY (MORNING AND EVENING) | 0 | 20 | MG | ||||||||
| 126939251 | 12693925 | 17 | C | TRANSIPEG /00754501/ | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 5.9 G, 2X/DAY (MORNING AND MIDDAY) | 0 | 5.9 | G | POWDER FOR ORAL SOLUTION | BID | ||||||
| 126939251 | 12693925 | 18 | C | DAFALGAN | ACETAMINOPHEN | 1 | Oral | 1 DF, AS NEEDED | 0 | 1 | DF | ||||||||
| 126939251 | 12693925 | 19 | C | SPASFON /00765801/ | PHLOROGLUCINOL1,3,5-TRIMETHOXYBENZENE | 1 | Oral | 1 DF, AS NEEDED | 0 | 1 | DF | ||||||||
| 126939251 | 12693925 | 20 | C | SEVREDOL | MORPHINE | 1 | Oral | 1 DF, AS NEEDED | 0 | 1 | DF | ||||||||
| 126939251 | 12693925 | 21 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | 1 DF, AS NEEDED | 0 | 1 | DF | ||||||||
| 126939251 | 12693925 | 22 | C | BIOCIDAN | 2 | UNK | 0 | EYE DROPS | |||||||||||
| 126939251 | 12693925 | 23 | C | EDUCTYL | POTASSIUM BITARTRATESODIUM BICARBONATE | 1 | UNK | 0 | SUPPOSITORY | ||||||||||
| 126939251 | 12693925 | 24 | C | NORMACOL /00086101/ | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 126939251 | 12693925 | 25 | C | LANSOYL | MINERAL OIL | 1 | UNK | 0 | |||||||||||
| 126939251 | 12693925 | 26 | C | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126939251 | 12693925 | 1 | Bronchial carcinoma |
| 126939251 | 12693925 | 2 | Bronchial carcinoma |
| 126939251 | 12693925 | 18 | Pain |
| 126939251 | 12693925 | 19 | Pain |
| 126939251 | 12693925 | 20 | Pain |
| 126939251 | 12693925 | 21 | Nausea |
| 126939251 | 12693925 | 24 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126939251 | 12693925 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126939251 | 12693925 | Anaemia | |
| 126939251 | 12693925 | Haemoptysis | |
| 126939251 | 12693925 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126939251 | 12693925 | 1 | 20150403 | 20150403 | 0 | |
| 126939251 | 12693925 | 2 | 20150403 | 0 | ||
| 126939251 | 12693925 | 3 | 20150410 | 0 |